Fact CheckerSign in

NCT03481881Recruiting

Pharmacokinetics of Drugs Administered to Children

Pharmacokinetics of Drugs Administered to Children Per Standard of Care

Source: ClinicalTrials.gov · Last updated 7 Jan 2026

Brief summary (registry, in English)

This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
14 Mar 2018
Start date
14 Aug 2013
Primary completion date
14 Aug 2033
Lead sponsor
Duke University
NCT number
NCT03481881

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 14 Aug 2013 to the primary completion date, 14 Aug 2033
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Failure to obtain consent/assent (as indicated)

Who the study is looking for

  • Children (\< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver

Age in the registry: 0 years to 20 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Duke University
Coordinator of this site? Confirm its status
DurhamUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.